Overt and incomplete (silent) cerebral infarction in sickle cell anemia: Diagnosis and management

Hematology/Oncology Clinics of North America

Volumn 19, Issue 5, 2005, Pages 839-855

  Wong, Wing Yen ^a   Powars, Darleen R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMPHETAMINE; ANTIINFLAMMATORY AGENT; APICIDIN; CALCIUM CHANNEL BLOCKING AGENT; CHELATING AGENT; DEFERIPRONE; DEFEROSIROX; DEFEROXAMINE; DEFEROXAMINE MESYLATE; DOPAMINE RECEPTOR STIMULATING AGENT; GLYCINE RECEPTOR ANTAGONIST; HYDROXYUREA; IRON CHELATE; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; ROPINIROLE; SCAVENGER; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BLOOD TRANSFUSION; BRAIN ATROPHY; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ECHOGRAPHY; GROWTH RETARDATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NAUSEA AND VOMITING; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOTOXICITY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; SIDE EFFECT; STROKE;

AGE FACTORS; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CEREBRAL INFARCTION; HUMANS; HYDROXYUREA; RISK FACTORS;

EID: 26444499508     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2005.07.006     Document Type: Review

References (73)

1. C.H. Pegelow, W. Wang, and S. Granger Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity Arch Neurol 58 2001 2017 2021
2. M. Prengler, S.G. Pavlakis, and I. Prohovnik Sickle cell disease: the neurological complications Ann Neurol 51 2002 543 552
3. R.L. Grubb, C.P. Derdeyn, and S.M. Fritsch Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion JAMA 280 1998 1055 1060
4. K. Ohene-Frempong, S.J. Weiner, L.A. Sleeper and the Cooperative Study of Sickle Cell Disease Cerebrovascular accidents in sickle cell disease: rates and risk factors Blood 91 1998 228 294
5. D.R. Powars, B. Wilson, and C. Imbus The natural history of stroke in sickle cell disease Am J Med 65 1978 461 471
6. R.J. Adams, K. Ohene-Frempong, and W. Wang Sickle cell and the brain Hematology (Am Soc Hematol Educ Program) 2001 31 46
7. W.C. Wang, D.M. Gallagher, and C.H. Pegelow Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease J Pediatr Hematol Oncol 22 2000 335 339
8. R.G. Steen, T. Emudianughe, and G.M. Hankins Brain imaging findings in pediatric patients with sickle cell disease Radiology 228 2003 216 225
9. J.H. Garcia, N.J. Lassen, and C. Weiller Ischemic stroke and incomplete infarction Stroke 27 1996 761 765
10. M. Koshy, C. Thomas, and J. Goodwin Vascular lesions in the central nervous system in sickle cell disease (neuropathology) JAAMP 1 1990 71 78
11. D.R. Powars, P.S. Conti, and W.Y. Wong Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography Blood 93 1999 71 79
12. M.C. Driscoll, A. Hurlet, and L. Styles Stroke risk in siblings with sickle cell anemia Blood 101 2003 2401 2404
13. C. Hoppe, W. Klitz, and J. Noble Distinct HLA associations by stroke in children with sickle cell anemia Blood 101 2003 2865 2869
14. L.L. Hsu, S.T. Miller, and E. Wright Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia J Pediatr Hematol Oncol 25 2003 622 628
15. W. Huang, H. Wang, and R. Kekuda Transport of N-acetylaspartate by the Na+-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain Pharmacology 295 2000 392 403
16. R.G. Steen, and R.J. Ogg Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease AJNR Am J Neuroradiol 26 2005 463 468
17. S.T. Miller, L.A. Sleeper, and C.H. Pegelow Prediction of adverse outcomes in children with sickle cell disease: a report from the Cooperative Study (CSSCD) N Engl J Med 342 2000 83 89
18. T.A. Glauser, M.J. Siegel, and B.C.P. Lee Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy J Child Neurol 10 1995 88 92
19. W.C. Wang, J.W. Langston, and R.G. Steen Abnormalities of the central nervous system in very young children with sickle cell anemia J Pediatr 132 1998 994 998
20. S.T. Miller, E.A. Macklin, and C.H. Pegelow Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease J Pediatr 139 2001 385 390
21. D.J. Scothorn, C. Price, and D. Schwartz Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke J Pediatr 140 2002 348 354
22. F.J. Kirkham, F. Calamante, and M. Bynevelt Perfusion magnetic resonance abnormalities in patients with sickle cell disease Ann Neurol 49 4 2001 477 485
23. S.R. Dobson, K.R. Holden, and P.J. Nietert Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events Blood 99 2002 3144 3150
24. A.V. Swift, M.J. Cohen, and G.W. Hynd Neuropsychologic impairment in children with sickle cell anemia An Pediatr (Barc) 84 1989 1077 1085
25. R.J. Adams Stroke prevention and treatment in sickle cell disease Arch Neurol 58 2001 565 568
26. C.T. Quinn, Z.R. Rogers, and G.R. Buchanan Survival of children with sickle cell disease Blood 103 2004 4023 4027
27. D.R. Powars Management of cerebral vasculopathy in children with sickle cell anaemia Br J Haematol l108 2000 666 678
28. C.J. Earley, S.J. Kittner, and B.R. Feeser Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study Neurology 51 1998 169 176
29. L.V. Gabis, R. Yangala, and N.J. Lenn Time lag to diagnosis of stroke in children An Pediatr (Barc) 110 2002 924 928
30. M.L. Katz, K. Smith-Whitley, and S.B. Ruzek Knowledge of stroke risk, signs of stroke, and the need for stroke education among children with sickle cell disease and their caregivers Ethn Health 7 2002 115 123
31. F.D. Armstrong, R.J. Thompson Jr, and W. Wang Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease An Pediatr (Barc) 97 1996 864 870
32. S. Craft, J. Schatz, and T.A. Glauser Neuropsychologic effects of stroke in children with sickle cell anemia J Pediatr 123 1993 712 717
33. F. Bernaudin, S. Verlhac, and F. Freard Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation J Child Neurol 15 2000 333 343
34. J. Schatz, D.A. White, and A. Moinuddin Lesion burden and cognitive morbidity in children with sickle cell disease J Child Neurol 17 2002 891 895
35. C.H. Pegelow, E.A. Macklin, and F.G. Moser Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease Blood 99 2002 3014 3018
36. R.J. Adams Lessons from the stroke prevention trial in sickle cell anemia (STOP) study J Child Neurol 15 2000 344 349
37. M.R. Abboud, J. Cure, and S. Granger Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study Blood 103 2004 2822 2826
38. S.E. Vermeer, N.D. Prins, and T. den Heijer Silent brain infarcts and the risk of dementia and cognitive decline N Engl J Med 348 2003 1215 1222
39. C.J. Moran, M.J. Siegel, and M.R. DeBaun Sickle cell disease: imaging of cerebrovascular complications Radiology 206 1998 311 321
40. M.E. Mullins, P.W. Schaefer, and A.G. Sorensen CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department Radiology 224 2 2002 356 360
41. T. Moritani, Y. Numaguchy, and N.B. Lemer Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography Clin Imag 28 2004 173 186
42. R.G. Steen, W.E. Reddick, and R.K. Mulhern Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI J Magn Reson Imaging 8 1998 535 543
43. R.A. Crisostomo, M.M. Garcia, and D.C. Tong Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics Stroke 34 2003 932 937
44. P.W. Schaefer, Y. Ozsunar, and J. He Assessing tissue viability with MR diffusion and perfusion imaging AJNR Am J Neuroradiol 24 3 2003 436 443
45. A.Y. Kandeel, R.A. Zimmerman, and K. Ohene-Frempong Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability Neuroradiology 38 1996 409 416
46. R.J. Adams, D.J. Brambilla, and S. Granger Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study Blood 103 2004 3689 3694
47. N. Venketasubramanian, I. Prohovnik, and A. Hurlet Middle cerebral artery velocity changes during transfusion in sickle cell anemia Stroke 25 1994 2153 2158
48. K. Noguchi, T. Ogawa, and A. Inugami Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences Radiology 196 1995 773 777
49. O. Witt, S. Monkemeyer, and G. Ronndahl Induction of fetal hemoglobin expression by the histone-deacetylase inhibitor apicidin Blood 101 2003 2001 2007
50. Z.R. Rogers, and G.R. Buchanan Expanding the role of hydroxyurea in children with sickle cell disease J Pediatr 145 2004 287 288
51. T. Brott, and J. Bogousslavsky Treatment of acute ischemic stroke N Engl J Med 343 2000 710 722
52. K. Scheidtmann, W. Fries, and F. Muller Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomized, double-blind study Lancet 358 2001 787 790
53. M. Schoning, and B. Hartig Age dependence of total cerebral blood flow volume from childhood to adulthood J Cereb Blood Flow Metab 16 1996 827 833
54. P.R. Huttenlocher, J.W. Moohr, and L. Johns Cerebral blood flow in sickle cerebrovascular disease An Pediatr (Barc) 73 5 1984 615 621
55. A. Raj, S.J. Bertolone, and S. Mangold Assessment of cerebral tissue oxygenation in patients with sickle cell disease: effect of transfusion therapy J Pediatr Hematol Oncol 26 2004 279 283
56. G.R. Buchanan, W.P. Bowman, and S.J. Smith Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia J Pediatr 103 1983 921 923
57. C.H. Pegelow, R.J. Adams, and V. McKie Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions J Pediatr 126 6 1995 896 899
58. M.O. Russell, H.I. Goldberg, and A. Hodson Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease Blood 63 1 1984 162 169
59. A.R. Cohen, M.B. Martin, and J.H. Silber A modified transfusion program for prevention of stroke in sickle cell disease Blood 79 1992 1657 1661
60. N.F. Olivieri Progression of iron overload in sickle cell disease Semin Hematol 38 2001 57 62
61. R.E. Ware, S.A. Zimmerman, and W.H. Schultz Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease Blood 94 1999 3022 3026
62. A. Sumoza, R. de Bisotti, and D. Sumoza Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA) Am J Hematol 71 2002 161 165
63. S.A. Zimmerman, W.H. Schultz, and J.S. Davis Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease Blood 103 2004 2039 2045
64. M.H. Steinberg, F. Barton, and O. Castro Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment JAMA 289 2003 1645 1651
65. S. Rana, P.E. Houston, and N. Surana Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke J Pediatr 131 1997 757 760
66. R.E. Ware, S.A. Zimmerman, and P.B. Sylvestre Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy J Pediatr 145 2004 346 352
67. W.C. Wang, L.W. Wynn, and Z.R. Rogers A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia J Pediatr 139 2001 790 796
68. P.L. Jackson, M.F. Lafleur, and F. Malouin Functional cerebral reorganization following motor sequence learning through mental practice with motor imagery Neuroimage 20 2003 1171 1180
69. J.A. Stevens, and M.E. Stoykov Using motor imagery in the rehabilitation of hemiparesis Arch Phys Med Rehabil 84 2003 1090 1092
70. E. Taub, G. Uswatte, and R.D. Pidikiti Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation. A clinical review J Rehab Res Dev 36 1999 237 251
71. C.J. Winstein, A.M. Wing, and J. Whitall Motor control and learning principles for rehabilitation of upper limb movements after brain injury J. Grafman I. Robertson Plasticity and rehabilitation 2nd edition. (Handbook of neuropsychology, vol. 9) 2003 Elsevier Science BV Amsterdam 77 137
72. J. van der Lee, R. Wagenaar, and G. Lankhorst Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial Stroke 30 1999 2369 2375
73. D.J. Gladstone, and S.E. Black Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci 27 2000 97 105